Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897874776> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W2897874776 abstract "Background: The impact of the preceding use of concomitant use of antiplatelet and anticoagulation therapies on outcomes of intracerebral hemorrhage (ICH) has not been thoroughly investigated. Methods: We analyzed 138,834 patients presenting with ICH between October 2013 and December 2016 from 1661 hospitals participating in the Get With The Guidelines-Stroke program. Multivariable logistic regression was used to evaluate the impact of concomitant antiplatelet therapy on in-hospital mortality in anticoagulation-related ICH. Results: Of 138,834 patients (mean [SD] age 68.4 [15.3] years; 48.0% women), 118,219 (85.2%) patients were not receiving any oral anticoagulant (OAC), 15,777 (11.4%) were receiving warfarin and 4,838 (3.5%) were receiving non-vitamin K oral anticoagulants (NOACs) prior to ICH. Stroke severity as measured by NIHSS was similar across three groups. Patients receiving warfarin or NOACs were more likely to have single antiplatelet therapy (SAPT) than those receiving no OAC (33.0% for warfarin, 30.7% for NOACs, and 27.3% for no OAC), whereas patients receiving no OAC were more likely to have dual antiplatelet therapy (DAPT) (2.5% for warfarin, 2.3% for NOACs, and 4.4% for no OAC). After adjustment for confounders, SAPT was associated with a slightly higher rate of mortality (33.8% vs. 32.1%, adjusted odds ratio [AOR] = 1.20, 95% CI [1.11-1.30]) than no antiplatelet in patients receiving warfarin, whereas there were no statistically significant differences between SAPT vs. no antiplatelet in patients with no OAC (22.4% vs. 22.9%, AOR = 0.99 [0.95-1.03]) or NOACs (26.8% vs. 26.9%, AOR = 1.09 [0.94-1.26]). DAPT was associated with increased risk of death in patients taking warfarin (46.5% vs. 32.1%, AOR = 2.08 [95% CI, 1.68-2.57]) and no OAC (30.4% vs. 22.9%, AOR = 1.51 [95% CI, 1.40-1.63]). By contrast, in patients taking NOACs, the association of DAPT was not significant but the confidence intervals were wider (32.7% vs. 26.9%, AOR = 1.37 [95% CI, 0.90-2.08]) likely due to small sample size. Conclusions: In patients experienced an ICH, prior concomitant use of antiplatelet therapy (either SAPT or DAPT) significantly increased odds of mortality in patients taking warfarin, but such a difference was not apparent in NOAC-treated ICH patients." @default.
- W2897874776 created "2018-10-26" @default.
- W2897874776 creator A5010571732 @default.
- W2897874776 creator A5012849300 @default.
- W2897874776 creator A5015783013 @default.
- W2897874776 creator A5020723643 @default.
- W2897874776 creator A5038719267 @default.
- W2897874776 creator A5064564309 @default.
- W2897874776 creator A5070062505 @default.
- W2897874776 creator A5070928171 @default.
- W2897874776 creator A5075359983 @default.
- W2897874776 creator A5085175606 @default.
- W2897874776 creator A5088160405 @default.
- W2897874776 creator A5088527297 @default.
- W2897874776 date "2018-01-22" @default.
- W2897874776 modified "2023-09-25" @default.
- W2897874776 title "Abstract 131: Impact of Concomitant Use of Antiplatelet and Anticoagulation Therapies on Outcomes in Patients With Intracerebral Hemorrhage" @default.
- W2897874776 doi "https://doi.org/10.1161/str.49.suppl_1.131" @default.
- W2897874776 hasPublicationYear "2018" @default.
- W2897874776 type Work @default.
- W2897874776 sameAs 2897874776 @default.
- W2897874776 citedByCount "0" @default.
- W2897874776 crossrefType "journal-article" @default.
- W2897874776 hasAuthorship W2897874776A5010571732 @default.
- W2897874776 hasAuthorship W2897874776A5012849300 @default.
- W2897874776 hasAuthorship W2897874776A5015783013 @default.
- W2897874776 hasAuthorship W2897874776A5020723643 @default.
- W2897874776 hasAuthorship W2897874776A5038719267 @default.
- W2897874776 hasAuthorship W2897874776A5064564309 @default.
- W2897874776 hasAuthorship W2897874776A5070062505 @default.
- W2897874776 hasAuthorship W2897874776A5070928171 @default.
- W2897874776 hasAuthorship W2897874776A5075359983 @default.
- W2897874776 hasAuthorship W2897874776A5085175606 @default.
- W2897874776 hasAuthorship W2897874776A5088160405 @default.
- W2897874776 hasAuthorship W2897874776A5088527297 @default.
- W2897874776 hasConcept C126322002 @default.
- W2897874776 hasConcept C127413603 @default.
- W2897874776 hasConcept C177713679 @default.
- W2897874776 hasConcept C2776301958 @default.
- W2897874776 hasConcept C2776413415 @default.
- W2897874776 hasConcept C2777094939 @default.
- W2897874776 hasConcept C2777736543 @default.
- W2897874776 hasConcept C2778810321 @default.
- W2897874776 hasConcept C2779161974 @default.
- W2897874776 hasConcept C2779384505 @default.
- W2897874776 hasConcept C2780645631 @default.
- W2897874776 hasConcept C71924100 @default.
- W2897874776 hasConcept C78519656 @default.
- W2897874776 hasConceptScore W2897874776C126322002 @default.
- W2897874776 hasConceptScore W2897874776C127413603 @default.
- W2897874776 hasConceptScore W2897874776C177713679 @default.
- W2897874776 hasConceptScore W2897874776C2776301958 @default.
- W2897874776 hasConceptScore W2897874776C2776413415 @default.
- W2897874776 hasConceptScore W2897874776C2777094939 @default.
- W2897874776 hasConceptScore W2897874776C2777736543 @default.
- W2897874776 hasConceptScore W2897874776C2778810321 @default.
- W2897874776 hasConceptScore W2897874776C2779161974 @default.
- W2897874776 hasConceptScore W2897874776C2779384505 @default.
- W2897874776 hasConceptScore W2897874776C2780645631 @default.
- W2897874776 hasConceptScore W2897874776C71924100 @default.
- W2897874776 hasConceptScore W2897874776C78519656 @default.
- W2897874776 hasIssue "Suppl_1" @default.
- W2897874776 hasLocation W28978747761 @default.
- W2897874776 hasOpenAccess W2897874776 @default.
- W2897874776 hasPrimaryLocation W28978747761 @default.
- W2897874776 hasRelatedWork W113121458 @default.
- W2897874776 hasRelatedWork W1978850334 @default.
- W2897874776 hasRelatedWork W2028819591 @default.
- W2897874776 hasRelatedWork W2035948536 @default.
- W2897874776 hasRelatedWork W2039135052 @default.
- W2897874776 hasRelatedWork W2052776918 @default.
- W2897874776 hasRelatedWork W2066744512 @default.
- W2897874776 hasRelatedWork W2100511295 @default.
- W2897874776 hasRelatedWork W2103269932 @default.
- W2897874776 hasRelatedWork W2119163410 @default.
- W2897874776 hasRelatedWork W2800413366 @default.
- W2897874776 hasRelatedWork W2804692193 @default.
- W2897874776 hasRelatedWork W3000081526 @default.
- W2897874776 hasRelatedWork W3003546595 @default.
- W2897874776 hasRelatedWork W3138158272 @default.
- W2897874776 hasRelatedWork W3138216550 @default.
- W2897874776 hasRelatedWork W3138780748 @default.
- W2897874776 hasRelatedWork W3165618992 @default.
- W2897874776 hasRelatedWork W3180087738 @default.
- W2897874776 hasRelatedWork W81167571 @default.
- W2897874776 hasVolume "49" @default.
- W2897874776 isParatext "false" @default.
- W2897874776 isRetracted "false" @default.
- W2897874776 magId "2897874776" @default.
- W2897874776 workType "article" @default.